发明名称 RECOMBINANT ALPHAVIRUS-BASED VECTOR WITH REDUCED INHIBITION OF CELLULAR MACROMOLECULAR SYNTHESIS
摘要 <P>PROBLEM TO BE SOLVED: To provide a recombinant vector having a selected desired phenotype useful in various applications (including gene therapy and recombinant protein production) and other related advantages. <P>SOLUTION: The isolated nucleic acid molecule comprises an alphavirus nonstructural protein gene which, when operably incorporated into a recombinant alphavirus particle, increases the time required to reach 50% inhibition of host cell-directed macromolecular synthesis following expression in mammalian cells, as compared to a wild-type alphavirus. <P>COPYRIGHT: (C)2009,JPO&INPIT
申请公布号 JP2009159962(A) 申请公布日期 2009.07.23
申请号 JP20090001186 申请日期 2009.01.06
申请人 NOVARTIS VACCINES & DIAGNOSTICS INC;WASHINGTON UNIV 发明人 DUBENSKY THOMAS W JR;POLO JOHN M;BELLI BARBARA A;SCHLESINGER SONDRA;DRYGA SERGEY A;FROLOV ILYA
分类号 C12N15/09;A61K31/7105;A61K35/76;A61K39/00;A61K48/00;C07K14/005;C07K14/18;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N7/00;C12N7/01;C12N7/04;C12N15/19;C12N15/24;C12N15/79;C12N15/86 主分类号 C12N15/09
代理机构 代理人
主权项
地址